Рамиприл Тева 5 мг

国家: 以色列

语言: 俄文

来源: Ministry of Health

现在购买

有效成分:

RAMIPRIL 5 MG

可用日期:

TEVA PHARMACEUTICAL INDUST.LTD

ATC代码:

C09AA05

药物剂型:

TABLETS

给药途径:

PER OS

厂商:

TEVA PHARMACEUTICAL INDUSTRIES LTD

治疗组:

RAMIPRIL

疗效迹象:

- Hypertension - Congestive heart failure - Reduction of mortality in patients after MI with left ventricular dysfunction For reducing the risk of myocardial infarction stoke cardiovascular death or need for revascularization procedures in patients over 55 years or more who have clinical evidence of cardiovascular disease (previous MI unstable angina or multivessel CABG or multivessel PTCA) stroke or peripheral vascular disease. Also for reducing the risk of myocardial infarction stroke cardiovascular death or need for revascularization procedures in diabetic patients of 55 years or more who have one or more of the following clinical findings : hypertension (systolic blood pressure > 160 mmHg or diastolic pressure > 90 mmHg) high total cholesterol (>5.2 mmol/L) low HDL ( <0.9 mmol/L) current smoker known microalbuminuria clinical evidence of previous vascular disease. - Prevention of progressive renal failure in patients with persistent proteinuria in excess of 1g/day.

授权日期:

2010-05-01

其他语言的文件

资料单张 资料单张 英文 29-01-2019
资料单张 资料单张 阿拉伯文 13-08-2019
资料单张 资料单张 希伯来文 13-08-2019

搜索与此产品相关的警报